| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.907 | 0.004 | 0.907 | Analgesic | 0.885 0.005 DBMET02503 0.885 0.005 DBMET02504 0.878 0.005 DBMET02505 0.752 0.009 DBMET00731 0.871 0.005 DBMET02506 0.838 0.005 DBMET02507 0.242 0.19 DBMET00750 0.701 0.013 DBMET02509 | ||
| 0.637 | 0.004 | 0.637 | 5 Hydroxytryptamine uptake inhibitor | 0.535 0.004 DBMET02503 0.535 0.004 DBMET02504 0.522 0.004 DBMET02505 0.178 0.013 DBMET00731 0.501 0.004 DBMET02506 0.456 0.004 DBMET02507 0.261 0.008 DBMET00750 0.131 0.019 DBMET02509 | ||
| 0.542 | 0.003 | 0.542 | Adrenaline uptake inhibitor | 0.458 0.004 DBMET02503 0.458 0.004 DBMET02504 0.442 0.004 DBMET02505 0.216 0.005 DBMET00731 0.432 0.004 DBMET02506 0.374 0.004 DBMET02507 0.234 0.005 DBMET00750 0.173 0.008 DBMET02509 | ||
| 0.491 | 0.003 | 0.491 | Nitric-oxide synthase inhibitor | 0.42 0.003 DBMET02503 0.42 0.003 DBMET02504 0.367 0.004 DBMET02505 0.1 0.059 DBMET00731 0.425 0.003 DBMET02506 0.354 0.004 DBMET02507 0.138 0.028 DBMET00750 | ||
| 0.501 | 0.028 | 0.512 | Calcium channel L-type activator | 0.5 0.028 DBMET02503 0.5 0.028 DBMET02504 0.512 0.024 DBMET02505 0.385 0.091 DBMET00731 0.489 0.032 DBMET02506 0.48 0.036 DBMET02507 0.388 0.089 DBMET00750 0.372 0.101 DBMET02509 | DBMET02505 | |
| 0.358 | 0.004 | 0.358 | Inducible nitric-oxide synthase inhibitor | 0.339 0.004 DBMET02503 0.339 0.004 DBMET02504 0.295 0.004 DBMET02505 0.077 0.068 DBMET00731 0.352 0.004 DBMET02506 0.311 0.004 DBMET02507 0.179 0.011 DBMET00750 | ||
| 0.322 | 0.018 | 0.322 | 5 Hydroxytryptamine 1E antagonist | 0.312 0.023 DBMET02503 0.312 0.023 DBMET02504 0.317 0.02 DBMET02505 0.293 0.035 DBMET02506 0.291 0.036 DBMET02507 | ||
| 0.313 | 0.012 | 0.313 | Antipruritic | 0.31 0.013 DBMET02503 0.31 0.013 DBMET02504 0.313 0.012 DBMET02505 0.217 0.038 DBMET00731 0.279 0.018 DBMET02506 0.239 0.028 DBMET02507 0.129 0.124 DBMET02509 | ||
| 0.287 | 0.004 | 0.287 | Toll-Like receptor 3 antagonist | 0.239 0.004 DBMET02503 0.239 0.004 DBMET02504 0.232 0.005 DBMET02505 0.117 0.032 DBMET00731 0.228 0.005 DBMET02506 0.235 0.005 DBMET02507 0.199 0.006 DBMET00750 0.122 0.028 DBMET02509 | ||
| 0.266 | 0.012 | 0.3 | Alpha 2b adrenoreceptor antagonist | 0.238 0.016 DBMET02503 0.238 0.016 DBMET02504 0.233 0.017 DBMET02505 0.269 0.012 DBMET02506 0.3 0.009 DBMET02507 | DBMET02507 | |
| 0.246 | 0.005 | 0.246 | Dopamine uptake inhibitor | 0.161 0.009 DBMET02503 0.161 0.009 DBMET02504 0.183 0.007 DBMET02505 0.161 0.009 DBMET02506 0.136 0.012 DBMET02507 | ||
| 0.236 | 0.009 | 0.236 | Nav1.5 sodium channel blocker | 0.161 0.022 DBMET02503 0.161 0.022 DBMET02504 0.162 0.021 DBMET02505 0.143 0.031 DBMET02506 0.124 0.05 DBMET02507 | ||
| 0.34 | 0.124 | 0.424 | 5 Hydroxytryptamine release inhibitor | 0.317 0.147 DBMET02503 0.317 0.147 DBMET02504 0.355 0.111 DBMET02505 0.424 0.064 DBMET00731 0.285 0.183 DBMET02506 0.295 0.171 DBMET02507 0.4 0.078 DBMET02509 | DBMET00731 | |
| 0.214 | 0.005 | 0.214 | TRPA1 antagonist | 0.195 0.005 DBMET02503 0.195 0.005 DBMET02504 0.182 0.006 DBMET02505 0.131 0.012 DBMET02506 0.083 0.023 DBMET02507 | ||
| 0.214 | 0.019 | 0.248 | Antibacterial (Helicobacter pylori) | 0.231 0.015 DBMET02503 0.231 0.015 DBMET02504 0.191 0.024 DBMET02505 0.129 0.068 DBMET00731 0.248 0.012 DBMET02506 0.243 0.013 DBMET02507 0.136 0.059 DBMET00750 0.125 0.074 DBMET02509 | DBMET02506 | |
| 0.206 | 0.01 | 0.234 | Aminoacyl-tRNA synthetase inhibitor | 0.234 0.009 DBMET02503 0.234 0.009 DBMET02504 0.191 0.012 DBMET02505 0.147 0.02 DBMET00731 0.183 0.012 DBMET02506 0.166 0.015 DBMET02507 0.132 0.025 DBMET02509 | DBMET02504 | |
| 0.24 | 0.058 | 0.385 | Peptidyltransferase inhibitor | 0.274 0.036 DBMET02503 0.274 0.036 DBMET02504 0.254 0.048 DBMET02505 0.385 0.008 DBMET00731 0.267 0.04 DBMET02506 0.242 0.056 DBMET02507 0.189 0.113 DBMET00750 0.369 0.009 DBMET02509 | DBMET00731 | |
| 0.266 | 0.087 | 0.396 | Hypoxia-inducible factor 1 alpha inhibitor | 0.331 0.052 DBMET02503 0.331 0.052 DBMET02504 0.347 0.046 DBMET02505 0.31 0.061 DBMET00731 0.379 0.036 DBMET02506 0.396 0.031 DBMET02507 0.221 0.128 DBMET00750 0.345 0.047 DBMET02509 | DBMET02507 | |
| 0.216 | 0.041 | 0.216 | 5 Hydroxytryptamine 3E antagonist | 0.165 0.152 DBMET02503 0.165 0.152 DBMET02504 0.168 0.143 DBMET02505 | ||
| 0.194 | 0.032 | 0.194 | 5 Hydroxytryptamine 2 antagonist | 0.121 0.058 DBMET02503 0.121 0.058 DBMET02504 0.119 0.059 DBMET02505 0.098 0.073 DBMET02506 0.121 0.058 DBMET02507 | ||
| 0.169 | 0.012 | 0.169 | CYP2A6 inhibitor | 0.112 0.03 DBMET02503 0.112 0.03 DBMET02504 0.11 0.031 DBMET02505 0.08 0.048 DBMET02506 | ||
| 0.158 | 0.005 | 0.208 | Beta adrenoreceptor antagonist | 0.178 0.004 DBMET02503 0.178 0.004 DBMET02504 0.195 0.004 DBMET02505 0.208 0.004 DBMET02506 0.199 0.004 DBMET02507 | DBMET02506 | |
| 0.172 | 0.02 | 0.172 | 5 Hydroxytryptamine 1 antagonist | 0.107 0.035 DBMET02503 0.107 0.035 DBMET02504 0.102 0.036 DBMET02505 0.079 0.047 DBMET02506 0.112 0.033 DBMET02507 | ||
| 0.181 | 0.037 | 0.181 | Sodium channel (voltage-gated) blocker | 0.106 0.103 DBMET02503 0.106 0.103 DBMET02504 0.112 0.094 DBMET02505 | ||
| 0.15 | 0.01 | 0.15 | Glutamate release inhibitor | 0.124 0.019 DBMET02503 0.124 0.019 DBMET02504 0.123 0.02 DBMET02505 0.137 0.013 DBMET00731 0.112 0.029 DBMET02506 0.115 0.026 DBMET02507 0.127 0.018 DBMET02509 | ||
| 0.161 | 0.028 | 0.185 | Alpha 2c adrenoreceptor antagonist | 0.143 0.036 DBMET02503 0.143 0.036 DBMET02504 0.146 0.034 DBMET02505 0.16 0.028 DBMET02506 0.185 0.021 DBMET02507 | DBMET02507 | |
| 0.173 | 0.041 | 0.173 | 5 Hydroxytryptamine antagonist | 0.096 0.083 DBMET02503 0.096 0.083 DBMET02504 0.093 0.085 DBMET02505 | ||
| 0.151 | 0.02 | 0.151 | 5 Hydroxytryptamine 1A antagonist | 0.106 0.03 DBMET02503 0.106 0.03 DBMET02504 0.099 0.032 DBMET02505 0.083 0.039 DBMET02506 0.116 0.027 DBMET02507 | ||
| 0.144 | 0.016 | 0.202 | Adrenaline agonist | 0.179 0.009 DBMET02503 0.179 0.009 DBMET02504 0.2 0.007 DBMET02505 0.202 0.007 DBMET02506 0.156 0.013 DBMET02507 | DBMET02506 | |
| 0.154 | 0.026 | 0.206 | Alpha 2 adrenoreceptor antagonist | 0.126 0.035 DBMET02503 0.126 0.035 DBMET02504 0.132 0.033 DBMET02505 0.191 0.019 DBMET02506 0.206 0.017 DBMET02507 | DBMET02507 | |
| 0.174 | 0.049 | 0.174 | Toll-Like receptor 9 antagonist | 0.121 0.085 DBMET02503 0.121 0.085 DBMET02504 0.14 0.07 DBMET02505 0.108 0.1 DBMET02506 0.139 0.07 DBMET02507 | ||
| 0.197 | 0.073 | 0.197 | I kappa B kinase epsilon inhibitor | 0.178 0.091 DBMET02503 0.178 0.091 DBMET02504 0.172 0.097 DBMET02505 0.159 0.11 DBMET02506 0.18 0.089 DBMET02507 | ||
| 0.149 | 0.027 | 0.149 | 5 Hydroxytryptamine 2C antagonist | 0.095 0.049 DBMET02503 0.095 0.049 DBMET02504 0.094 0.05 DBMET02505 0.081 0.06 DBMET02506 0.11 0.04 DBMET02507 | ||
| 0.128 | 0.008 | 0.128 | Dopamine transporter inhibitor | 0.104 0.011 DBMET02503 0.104 0.011 DBMET02504 0.102 0.011 DBMET02505 0.101 0.012 DBMET02506 0.091 0.014 DBMET02507 | ||
| 0.131 | 0.016 | 0.131 | Alpha 2d adrenoreceptor antagonist | 0.124 0.021 DBMET02503 0.124 0.021 DBMET02504 0.119 0.024 DBMET02505 0.117 0.026 DBMET02506 0.116 0.027 DBMET02507 | ||
| 0.249 | 0.136 | 0.469 | Vasodilator, coronary | 0.264 0.121 DBMET02503 0.264 0.121 DBMET02504 0.246 0.139 DBMET02505 0.416 0.03 DBMET00731 0.294 0.093 DBMET02506 0.324 0.07 DBMET02507 0.278 0.107 DBMET00750 0.469 0.02 DBMET02509 | DBMET02509 | |
| 0.185 | 0.079 | 0.185 | Growth factor agonist | 0.181 0.085 DBMET02503 0.181 0.085 DBMET02504 0.179 0.088 DBMET02505 0.169 0.104 DBMET02506 0.153 0.135 DBMET02507 | ||
| 0.119 | 0.014 | 0.138 | Acetylcholine M3 receptor antagonist | 0.124 0.014 DBMET02503 0.124 0.014 DBMET02504 0.138 0.012 DBMET02505 0.092 0.021 DBMET02506 0.075 0.029 DBMET02507 | DBMET02505 | |
| 0.142 | 0.038 | 0.167 | Antiadrenergic | 0.117 0.047 DBMET02503 0.117 0.047 DBMET02504 0.122 0.045 DBMET02505 0.163 0.032 DBMET02506 0.167 0.032 DBMET02507 | DBMET02507 | |
| 0.11 | 0.007 | 0.159 | Beta 2 adrenoreceptor antagonist | 0.133 0.005 DBMET02503 0.133 0.005 DBMET02504 0.148 0.004 DBMET02505 0.159 0.004 DBMET02506 0.136 0.005 DBMET02507 | DBMET02506 | |
| 0.142 | 0.039 | 0.227 | DNA repair enzyme inhibitor | 0.143 0.038 DBMET02503 0.143 0.038 DBMET02504 0.137 0.045 DBMET02505 0.227 0.006 DBMET00731 0.136 0.047 DBMET02506 0.136 0.047 DBMET02507 0.223 0.007 DBMET02509 | DBMET00731 | |
| 0.138 | 0.038 | 0.162 | Adrenaline antagonist | 0.113 0.047 DBMET02503 0.113 0.047 DBMET02504 0.118 0.045 DBMET02505 0.158 0.032 DBMET02506 0.162 0.031 DBMET02507 | DBMET02507 | |
| 0.183 | 0.09 | 0.248 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.222 0.056 DBMET02503 0.222 0.056 DBMET02504 0.227 0.054 DBMET02505 0.248 0.043 DBMET02506 0.239 0.048 DBMET02507 | DBMET02506 | |
| 0.139 | 0.051 | 0.139 | Acetylcholine muscarinic antagonist | 0.131 0.057 DBMET02503 0.131 0.057 DBMET02504 0.133 0.056 DBMET02505 0.131 0.057 DBMET02506 0.109 0.08 DBMET02507 | ||
| 0.213 | 0.128 | 0.362 | Lipoxygenase inhibitor | 0.32 0.062 DBMET02503 0.32 0.062 DBMET02504 0.324 0.06 DBMET02505 0.362 0.047 DBMET02506 0.346 0.052 DBMET02507 | DBMET02506 | |
| 0.144 | 0.064 | 0.144 | Calcium channel blocker | |||
| 0.142 | 0.064 | 0.142 | Sodium channel blocker | |||
| 0.09 | 0.013 | 0.121 | Beta 1 adrenoreceptor antagonist | 0.099 0.01 DBMET02503 0.099 0.01 DBMET02504 0.104 0.009 DBMET02505 0.121 0.007 DBMET02506 0.113 0.008 DBMET02507 | DBMET02506 | |
| 0.085 | 0.01 | 0.085 | 5 Hydroxytryptamine 1B agonist | 0.063 0.024 DBMET02503 0.063 0.024 DBMET02504 0.069 0.018 DBMET02505 0.058 0.029 DBMET02506 0.051 0.04 DBMET02507 | ||
| 0.175 | 0.103 | 0.175 | Anticonvulsant | |||
| 0.072 | 0.005 | 0.072 | Endothelial nitric-oxide synthase inhibitor | 0.04 0.013 DBMET02503 0.04 0.013 DBMET02504 0.031 0.022 DBMET02505 0.033 0.02 DBMET02506 | ||
| 0.077 | 0.011 | 0.09 | Beta 2 adrenoreceptor agonist | 0.087 0.006 DBMET02503 0.087 0.006 DBMET02504 0.089 0.005 DBMET02505 0.09 0.005 DBMET02506 0.077 0.011 DBMET02507 | DBMET02506 | |
| 0.136 | 0.072 | 0.136 | Nav1.6 sodium channel blocker | |||
| 0.084 | 0.021 | 0.096 | Alpha 2 adrenoreceptor agonist | 0.077 0.026 DBMET02503 0.077 0.026 DBMET02504 0.074 0.028 DBMET02505 0.096 0.016 DBMET02506 0.072 0.03 DBMET02507 | DBMET02506 | |
| 0.066 | 0.005 | 0.074 | Dopamine autoreceptor agonist | 0.072 0.005 DBMET02503 0.072 0.005 DBMET02504 0.074 0.005 DBMET02505 0.039 0.01 DBMET02506 0.033 0.012 DBMET02507 | DBMET02505 | |
| 0.098 | 0.038 | 0.147 | Alpha 2a adrenoreceptor antagonist | 0.088 0.043 DBMET02503 0.088 0.043 DBMET02504 0.093 0.04 DBMET02505 0.141 0.024 DBMET02506 0.147 0.023 DBMET02507 | DBMET02507 | |
| 0.077 | 0.017 | 0.115 | Factor IXa inhibitor | 0.069 0.021 DBMET02503 0.069 0.021 DBMET02504 0.073 0.019 DBMET02505 0.115 0.007 DBMET00731 0.061 0.025 DBMET02506 0.053 0.033 DBMET02507 0.084 0.014 DBMET00750 0.096 0.011 DBMET02509 | DBMET00731 | |
| 0.072 | 0.013 | 0.089 | Squalene epoxidase inhibitor | 0.073 0.012 DBMET02503 0.073 0.012 DBMET02504 0.073 0.012 DBMET02505 0.089 0.007 DBMET02506 0.056 0.025 DBMET02507 | DBMET02506 | |
| 0.116 | 0.059 | 0.168 | Mucolytic | 0.14 0.039 DBMET02503 0.14 0.039 DBMET02504 0.131 0.045 DBMET02505 0.142 0.037 DBMET00731 0.139 0.039 DBMET02506 0.155 0.029 DBMET02507 0.168 0.024 DBMET02509 | DBMET02509 | |
| 0.092 | 0.044 | 0.092 | Histamine H2 receptor antagonist | |||
| 0.12 | 0.074 | 0.12 | Cholinergic antagonist | 0.104 0.09 DBMET02503 0.104 0.09 DBMET02504 0.111 0.082 DBMET02505 0.102 0.093 DBMET02506 | ||
| 0.12 | 0.074 | 0.12 | Nav1.3 sodium channel blocker | |||
| 0.136 | 0.09 | 0.156 | Adenylate cyclase stimulant | 0.148 0.066 DBMET02503 0.148 0.066 DBMET02504 0.155 0.055 DBMET02505 0.156 0.054 DBMET02506 0.13 0.102 DBMET02507 | DBMET02506 | |
| 0.205 | 0.164 | 0.616 | Transcription factor NF kappa B inhibitor | 0.29 0.1 DBMET02503 0.29 0.1 DBMET02504 0.293 0.098 DBMET02505 0.582 0.033 DBMET00731 0.34 0.08 DBMET02506 0.348 0.078 DBMET02507 0.616 0.029 DBMET02509 | DBMET02509 | |
| 0.111 | 0.07 | 0.111 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.115 | 0.075 | 0.115 | Acetylcholine antagonist | 0.1 0.092 DBMET02503 0.1 0.092 DBMET02504 0.106 0.084 DBMET02505 0.099 0.094 DBMET02506 | ||
| 0.055 | 0.021 | 0.062 | Dopamine beta hydroxylase inhibitor | 0.058 0.017 DBMET02503 0.058 0.017 DBMET02504 0.057 0.018 DBMET02505 0.062 0.013 DBMET02506 0.047 0.038 DBMET02507 | DBMET02506 | |
| 0.048 | 0.016 | 0.048 | Glycine transporter 1 inhibitor | |||
| 0.117 | 0.086 | 0.117 | Nav1.2 sodium channel blocker | |||
| 0.246 | 0.218 | 0.684 | Cyclophilin D inhibitor | 0.286 0.176 DBMET02503 0.286 0.176 DBMET02504 0.269 0.192 DBMET02505 0.684 0.016 DBMET00731 0.302 0.161 DBMET02506 0.62 0.024 DBMET02509 | DBMET00731 | |
| 0.066 | 0.041 | 0.083 | Beta 3 adrenoreceptor antagonist | 0.073 0.03 DBMET02503 0.073 0.03 DBMET02504 0.083 0.021 DBMET02505 0.078 0.025 DBMET02506 0.07 0.033 DBMET02507 | DBMET02505 | |
| 0.104 | 0.079 | 0.112 | Anesthetic local | 0.112 0.073 DBMET02506 0.099 0.083 DBMET02507 | DBMET02506 | |
| 0.029 | 0.005 | 0.029 | Alpha 2a adrenoreceptor agonist | 0.019 0.01 DBMET02503 0.019 0.01 DBMET02504 0.019 0.01 DBMET02505 0.022 0.008 DBMET02506 | ||
| 0.092 | 0.068 | 0.092 | Interleukin 1 beta converting enzyme inhibitor | 0.089 0.074 DBMET02505 0.085 0.082 DBMET02506 | ||
| 0.07 | 0.046 | 0.083 | Alpha adrenoreceptor agonist | 0.059 0.056 DBMET02503 0.059 0.056 DBMET02504 0.062 0.053 DBMET02505 0.083 0.036 DBMET02506 0.073 0.043 DBMET02507 | DBMET02506 | |
| 0.043 | 0.02 | 0.043 | Glucagon-like peptide 1 receptor antagonist | 0.038 0.032 DBMET02503 0.038 0.032 DBMET02504 0.041 0.025 DBMET02505 0.039 0.028 DBMET02507 | ||
| 0.047 | 0.024 | 0.057 | Beta adrenoreceptor agonist | 0.053 0.013 DBMET02503 0.053 0.013 DBMET02504 0.057 0.01 DBMET02505 0.054 0.012 DBMET02506 0.046 0.028 DBMET02507 | DBMET02505 | |
| 0.103 | 0.08 | 0.116 | Acetylcholine release stimulant | 0.116 0.055 DBMET00750 0.097 0.094 DBMET02509 | DBMET00750 | |
| 0.051 | 0.031 | 0.051 | Glycine transporter inhibitor | |||
| 0.069 | 0.05 | 0.082 | Protein kinase C beta inhibitor | 0.07 0.047 DBMET02503 0.07 0.047 DBMET02504 0.073 0.042 DBMET02505 0.082 0.028 DBMET02506 | DBMET02506 | |
| 0.08 | 0.062 | 0.08 | Caspase 7 inhibitor | |||
| 0.122 | 0.105 | 0.136 | Acetylcholine M1 receptor antagonist | 0.123 0.105 DBMET02503 0.123 0.105 DBMET02504 0.118 0.111 DBMET02505 0.136 0.089 DBMET02506 | DBMET02506 | |
| 0.093 | 0.077 | 0.437 | Expectorant | 0.116 0.054 DBMET02503 0.116 0.054 DBMET02504 0.11 0.058 DBMET02505 0.34 0.006 DBMET00731 0.156 0.033 DBMET02506 0.184 0.024 DBMET02507 0.437 0.004 DBMET02509 | DBMET02509 | |
| 0.138 | 0.127 | 0.165 | Psychostimulant | 0.165 0.104 DBMET02503 0.165 0.104 DBMET02504 0.142 0.123 DBMET00731 | DBMET02504 | |
| 0.042 | 0.031 | 0.042 | Histamine H2 receptor agonist | |||
| 0.194 | 0.184 | 0.202 | Vasodilator, peripheral | 0.197 0.179 DBMET02503 0.197 0.179 DBMET02504 0.195 0.182 DBMET02505 0.202 0.174 DBMET02507 0.197 0.18 DBMET02509 | DBMET02507 | |
| 0.018 | 0.011 | 0.021 | KiSS-1 receptor antagonist | 0.021 0.009 DBMET02503 0.021 0.009 DBMET02504 0.018 0.011 DBMET02505 0.017 0.013 DBMET02506 | DBMET02504 | |
| 0.063 | 0.056 | 0.063 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.019 | 0.012 | 0.019 | Alpha 2c adrenoreceptor agonist | |||
| 0.11 | 0.104 | 0.114 | Interleukin 1 antagonist | 0.109 0.107 DBMET02506 0.114 0.099 DBMET02507 | DBMET02507 | |
| 0.028 | 0.022 | 0.038 | 1,3-Beta-glucan synthase inhibitor | 0.029 0.018 DBMET02503 0.029 0.018 DBMET02504 0.029 0.017 DBMET02505 0.032 0.011 DBMET00731 0.028 0.019 DBMET02506 0.038 0.004 DBMET00750 0.03 0.014 DBMET02509 | DBMET00750 | |
| 0.207 | 0.204 | 0.282 | Calcium channel activator | 0.282 0.11 DBMET02507 | DBMET02507 | |
| 0.019 | 0.017 | 0.019 | Imidazoline I1 receptor antagonist | |||
| 0.017 | 0.015 | 0.017 | Factor IX inhibitor | |||
| 0.075 | 0.073 | 0.092 | Ornithine decarboxylase inhibitor | 0.092 0.053 DBMET02503 0.092 0.053 DBMET02504 0.081 0.066 DBMET02505 0.081 0.066 DBMET02506 | DBMET02504 | |
| 0.025 | 0.024 | 0.025 | Bradykinin B2 receptor agonist | |||
| 0.112 | 0.113 | 0.291 | Cell wall synthesis inhibitor | 0.139 0.076 DBMET02503 0.139 0.076 DBMET02504 0.124 0.094 DBMET02505 0.291 0.01 DBMET00731 0.13 0.086 DBMET02506 0.115 0.107 DBMET00750 0.214 0.025 DBMET02509 | DBMET00731 | |
| 0.091 | 0.095 | 0.106 | Protein kinase C gamma inhibitor | 0.106 0.067 DBMET02505 0.106 0.067 DBMET02506 0.096 0.085 DBMET02507 | DBMET02506 | |
| 0.09 | 0.094 | 0.121 | Adenylate cyclase inhibitor | 0.112 0.074 DBMET02503 0.112 0.074 DBMET02504 0.121 0.067 DBMET02505 0.117 0.07 DBMET02506 | DBMET02505 | |
| 0.135 | 0.143 | 0.157 | Neurotensin receptor agonist | 0.153 0.095 DBMET02503 0.153 0.095 DBMET02504 0.157 0.085 DBMET02505 0.144 0.118 DBMET02507 | DBMET02505 | |
| 0.074 | 0.089 | 0.149 | 5-Lipoxygenase inhibitor | 0.135 0.044 DBMET02503 0.135 0.044 DBMET02504 0.123 0.049 DBMET02505 0.149 0.038 DBMET02506 0.121 0.049 DBMET02507 | DBMET02506 | |
| 0.068 | 0.084 | 0.1 | Alpha adrenoreceptor antagonist | 0.1 0.057 DBMET02507 | DBMET02507 | |
| 0.107 | 0.123 | 0.135 | Vanilloid 1 agonist | 0.129 0.067 DBMET02503 0.129 0.067 DBMET02504 0.115 0.101 DBMET02505 0.122 0.082 DBMET00731 0.125 0.077 DBMET02506 0.135 0.057 DBMET02507 0.13 0.067 DBMET02509 | DBMET02507 | |
| 0.182 | 0.199 | 0.295 | Caspase 3 stimulant | 0.232 0.129 DBMET02503 0.232 0.129 DBMET02504 0.241 0.121 DBMET02505 0.253 0.109 DBMET00731 0.211 0.153 DBMET02506 0.246 0.116 DBMET02507 0.295 0.081 DBMET02509 | DBMET02509 | |
| 0.043 | 0.061 | 0.06 | Leukotriene B4 antagonist | 0.052 0.04 DBMET02503 0.052 0.04 DBMET02504 0.05 0.043 DBMET02505 0.06 0.028 DBMET00731 0.055 0.035 DBMET02509 | DBMET00731 | |
| 0.085 | 0.103 | 0.092 | Folate antagonist | 0.092 0.082 DBMET00731 | DBMET00731 | |
| 0.016 | 0.035 | 0.023 | Beta 1 adrenoreceptor agonist | 0.023 0.015 DBMET02505 | DBMET02505 | |
| 0.084 | 0.105 | 0.098 | Interleukin 1b antagonist | 0.098 0.083 DBMET02507 | DBMET02507 | |
| 0.039 | 0.06 | 0.052 | Topoisomerase II beta inhibitor | 0.051 0.031 DBMET02505 0.052 0.03 DBMET02506 | DBMET02506 | |
| 0.127 | 0.15 | 0.258 | ATPase inhibitor | 0.143 0.113 DBMET02503 0.143 0.113 DBMET02504 0.258 0.012 DBMET00731 0.244 0.015 DBMET02509 | DBMET00731 | |
| 0.03 | 0.06 | 0.056 | NMDA 2A receptor antagonist | 0.045 0.043 DBMET02503 0.045 0.043 DBMET02504 0.056 0.033 DBMET02505 | DBMET02505 | |
| 0.039 | 0.069 | 0.057 | Protein kinase C eta inhibitor | 0.048 0.047 DBMET02505 0.057 0.036 DBMET02506 | DBMET02506 | |
| 0.059 | 0.09 | 0.111 | Macrophage migration inhibitory factor inhibitor | 0.071 0.064 DBMET02503 0.071 0.064 DBMET02504 0.111 0.029 DBMET02505 0.08 0.051 DBMET02506 0.076 0.057 DBMET02507 | DBMET02505 | |
| 0.07 | 0.102 | 0.108 | Urease inhibitor | 0.098 0.07 DBMET02503 0.098 0.07 DBMET02504 0.092 0.076 DBMET02505 0.108 0.058 DBMET02506 0.098 0.069 DBMET02507 | DBMET02506 | |
| 0.019 | 0.053 | 0.051 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.041 0.02 DBMET02503 0.041 0.02 DBMET02504 0.051 0.015 DBMET02505 0.034 0.026 DBMET02506 | DBMET02505 | |
| 0.139 | 0.176 | 0.255 | Spasmolytic | 0.181 0.136 DBMET02503 0.181 0.136 DBMET02504 0.171 0.144 DBMET02505 0.255 0.089 DBMET00731 0.201 0.119 DBMET02506 0.187 0.131 DBMET02507 0.234 0.098 DBMET02509 | DBMET00731 | |
| 0.038 | 0.077 | 0.087 | Glucose-6-phosphate translocase inhibitor | 0.083 0.01 DBMET00731 0.054 0.032 DBMET02506 0.056 0.029 DBMET02507 0.087 0.009 DBMET02509 | DBMET02509 | |
| 0.076 | 0.12 | 0.101 | MAO inhibitor | 0.101 0.09 DBMET02503 0.101 0.09 DBMET02504 0.101 0.089 DBMET02505 | DBMET02505 | |
| 0.084 | 0.127 | 0.113 | Electron transport complex I inhibitor | 0.113 0.057 DBMET02507 | DBMET02507 | |
| 0.061 | 0.106 | 0.089 | MAO A inhibitor | 0.086 0.074 DBMET02503 0.086 0.074 DBMET02504 0.089 0.072 DBMET02505 0.086 0.075 DBMET02506 | DBMET02505 | |
| 0.067 | 0.117 | 0.118 | ATPase (Vacuolar H+) inhibitor | 0.084 0.069 DBMET02503 0.084 0.069 DBMET02504 0.114 0.024 DBMET00731 0.08 0.079 DBMET02506 0.086 0.064 DBMET02507 0.118 0.021 DBMET02509 | DBMET02509 | |
| 0.121 | 0.174 | 0.163 | Insulin sensitizer | 0.163 0.116 DBMET02506 | DBMET02506 | |
| 0.006 | 0.059 | 0.023 | Ileal bile acid transport inhibitor | 0.02 0.009 DBMET00731 0.023 0.007 DBMET02509 | DBMET02509 | |
| 0.042 | 0.096 | 0.061 | Phenylalanine 4-hydroxylase inhibitor | 0.061 0.056 DBMET02506 | DBMET02506 | |
| 0.079 | 0.134 | 0.118 | Microtubule formation inhibitor | 0.11 0.074 DBMET00731 0.118 0.062 DBMET02509 | DBMET02509 | |
| 0.119 | 0.175 | 0.232 | Hypolipemic | 0.232 0.076 DBMET00731 0.197 0.096 DBMET02509 | DBMET00731 | |
| 0.118 | 0.175 | 0.276 | Non-steroidal antiinflammatory agent | 0.276 0.034 DBMET00731 0.138 0.134 DBMET02507 0.253 0.041 DBMET02509 | DBMET00731 | |
| 0.025 | 0.082 | 0.039 | NMDA receptor subunit 3B antagonist | 0.039 0.037 DBMET02503 0.039 0.037 DBMET02504 0.039 0.036 DBMET02505 | DBMET02505 | |
| 0.147 | 0.204 | 0.227 | Prostaglandin dehydrogenase inhibitor | 0.189 0.165 DBMET02503 0.189 0.165 DBMET02504 0.227 0.14 DBMET02506 0.183 0.169 DBMET02507 | DBMET02506 | |
| 0.153 | 0.219 | 0.359 | Cholesterol antagonist | 0.191 0.173 DBMET02505 0.359 0.061 DBMET00731 0.211 0.155 DBMET00750 0.329 0.074 DBMET02509 | DBMET00731 | |
| 0.079 | 0.146 | 0.105 | Aldehyde dehydrogenase inhibitor | 0.105 0.089 DBMET02505 | DBMET02505 | |
| 0.015 | 0.083 | 0.03 | Vanilloid 2 agonist | 0.03 0.01 DBMET00731 | DBMET00731 | |
| 0.066 | 0.134 | 0.083 | Protein kinase C zeta inhibitor | 0.083 0.078 DBMET02505 | DBMET02505 | |
| 0.042 | 0.123 | 0.128 | Topoisomerase II alpha inhibitor | 0.076 0.056 DBMET02505 0.126 0.028 DBMET00731 0.074 0.058 DBMET02506 0.081 0.052 DBMET02507 0.128 0.027 DBMET02509 | DBMET02509 | |
| 0.134 | 0.215 | 0.183 | 5 Hydroxytryptamine release stimulant | 0.183 0.137 DBMET02507 | DBMET02507 | |
| 0.094 | 0.175 | 0.211 | Insulin secretagoues | 0.211 0.031 DBMET00731 0.194 0.039 DBMET02509 | DBMET00731 | |
| 0.051 | 0.134 | 0.076 | Opioid kappa receptor antagonist | 0.076 0.065 DBMET02505 | DBMET02505 | |
| 0.034 | 0.125 | 0.059 | Dopamine D1 antagonist | 0.059 0.051 DBMET02506 | DBMET02506 | |
| 0.038 | 0.133 | 0.078 | Cathepsin G inhibitor | 0.078 0.045 DBMET00750 | DBMET00750 | |
| 0.026 | 0.129 | 0.311 | Selectin antagonist | 0.311 0.005 DBMET00731 0.116 0.023 DBMET00750 0.275 0.007 DBMET02509 | DBMET00731 | |
| 0.009 | 0.113 | 0.059 | Sodium/glucose cotransporter 2 inhibitor | 0.059 0.005 DBMET00731 0.033 0.011 DBMET02509 | DBMET00731 | |
| 0.009 | 0.115 | 0.018 | Antibiotic Anthracycline-like | 0.018 0.016 DBMET02509 | DBMET02509 | |
| 0.034 | 0.14 | 0.069 | CDC25B inhibitor | 0.069 0.039 DBMET02506 | DBMET02506 | |
| 0.151 | 0.266 | 0.257 | Sodium/bile acid cotransporter inhibitor | 0.209 0.176 DBMET02503 0.209 0.176 DBMET02504 0.257 0.121 DBMET02505 0.226 0.155 DBMET02507 0.196 0.193 DBMET00750 | DBMET02505 | |
| 0.155 | 0.279 | 0.206 | GABA C receptor rho-3 antagonist | 0.206 0.2 DBMET02503 0.206 0.2 DBMET02504 | DBMET02504 | |
| 0.032 | 0.157 | 0.069 | Factor III inhibitor | 0.049 0.037 DBMET00731 0.069 0.011 DBMET02509 | DBMET02509 | |
| 0.018 | 0.147 | 0.054 | Alpha tubulin antagonist | 0.054 0.036 DBMET02507 | DBMET02507 | |
| 0.02 | 0.149 | 0.063 | Antibiotic Aminoglycoside-like | 0.063 0.008 DBMET00731 0.058 0.009 DBMET02509 | DBMET00731 | |
| 0.045 | 0.175 | 0.186 | Mediator release inhibitor | 0.137 0.035 DBMET00731 0.088 0.083 DBMET02506 0.186 0.017 DBMET02509 | DBMET02509 | |
| 0.115 | 0.247 | 0.526 | Hypoglycemic | 0.17 0.147 DBMET02503 0.17 0.147 DBMET02504 0.526 0.013 DBMET00731 0.168 0.15 DBMET02506 0.476 0.018 DBMET02509 | DBMET00731 | |
| 0.087 | 0.223 | 0.225 | Antimitotic | 0.14 0.132 DBMET02506 0.225 0.071 DBMET02507 0.218 0.075 DBMET00750 | DBMET02507 | |
| 0.013 | 0.151 | 0.068 | Beta tubulin antagonist | 0.068 0.035 DBMET02507 | DBMET02507 | |
| 0.044 | 0.188 | 0.086 | Bronchodilator | 0.086 0.079 DBMET02507 | DBMET02507 | |
| 0.053 | 0.2 | 0.131 | Alkylator | 0.131 0.059 DBMET00731 0.129 0.06 DBMET02509 | DBMET00731 | |
| 0.01 | 0.159 | 0.116 | Dopamine D2 agonist | 0.05 0.026 DBMET02506 0.116 0.009 DBMET00750 | DBMET00750 | |
| 0.009 | 0.159 | 0.043 | Sodium/glucose cotransporter inhibitor | 0.043 0.006 DBMET00731 0.027 0.016 DBMET02509 | DBMET00731 | |
| 0.171 | 0.321 | 0.495 | Apoptosis agonist | 0.263 0.202 DBMET02503 0.263 0.202 DBMET02504 0.263 0.201 DBMET02505 0.468 0.085 DBMET00731 0.328 0.153 DBMET02506 0.34 0.145 DBMET02507 0.495 0.076 DBMET02509 | DBMET02509 | |
| 0.084 | 0.245 | 0.156 | P-glycoprotein inhibitor | 0.156 0.108 DBMET02507 0.147 0.122 DBMET02509 | DBMET02507 | |
| 0.133 | 0.295 | 0.303 | 15-Lipoxygenase inhibitor | 0.236 0.176 DBMET02503 0.236 0.176 DBMET02504 0.226 0.186 DBMET02505 0.303 0.13 DBMET02506 0.258 0.158 DBMET02507 | DBMET02506 | |
| 0.087 | 0.249 | 0.19 | Antiamyloidogenic | 0.158 0.136 DBMET00731 0.16 0.134 DBMET02507 0.19 0.107 DBMET02509 | DBMET02509 | |
| 0.095 | 0.257 | 0.253 | Vasodilator | 0.249 0.07 DBMET00731 0.181 0.121 DBMET02506 0.17 0.131 DBMET02507 0.253 0.067 DBMET02509 | DBMET02509 | |
| 0.082 | 0.251 | 0.157 | Melanin inhibitor | 0.157 0.073 DBMET00731 0.156 0.074 DBMET02509 | DBMET00731 | |
| 0.039 | 0.222 | 0.168 | Topoisomerase II inhibitor | 0.167 0.042 DBMET00731 0.095 0.091 DBMET02506 0.099 0.087 DBMET02507 0.168 0.042 DBMET02509 | DBMET02509 | |
| 0.043 | 0.227 | 0.163 | Tubulin antagonist | 0.163 0.052 DBMET02507 | DBMET02507 | |
| 0.007 | 0.191 | 0.042 | Dopamine D1 agonist | 0.027 0.011 DBMET02506 0.042 0.005 DBMET00750 0.022 0.017 DBMET02509 | DBMET00750 | |
| 0.03 | 0.223 | 0.127 | CDC25A inhibitor | 0.086 0.038 DBMET02506 0.127 0.017 DBMET00750 | DBMET00750 | |
| 0.173 | 0.366 | 0.298 | Caspase 9 stimulant | 0.259 0.242 DBMET02506 0.298 0.196 DBMET02507 | DBMET02507 | |
| 0.019 | 0.214 | 0.072 | Dopamine agonist | 0.072 0.043 DBMET02506 0.069 0.045 DBMET00750 | DBMET02506 | |
| 0.102 | 0.299 | 0.206 | 12-Lipoxygenase inhibitor | 0.206 0.145 DBMET02506 0.203 0.148 DBMET02507 | DBMET02506 | |
| 0.128 | 0.33 | 0.189 | Tyrosine 3 hydroxylase inhibitor | 0.189 0.157 DBMET02506 | DBMET02506 | |
| 0.009 | 0.215 | 0.03 | Protein 30S ribosomal subunit inhibitor | 0.03 0.013 DBMET00731 0.026 0.015 DBMET02509 | DBMET00731 | |
| 0.11 | 0.325 | 0.52 | Antithrombotic | 0.52 0.026 DBMET00731 0.467 0.034 DBMET02509 | DBMET00731 | |
| 0.068 | 0.283 | 0.218 | Interleukin agonist | 0.218 0.104 DBMET00731 0.176 0.143 DBMET02509 | DBMET00731 | |
| 0.041 | 0.26 | 0.112 | Estrogen receptor beta antagonist | 0.089 0.086 DBMET02503 0.089 0.086 DBMET02504 0.112 0.043 DBMET02505 | DBMET02505 | |
| 0.022 | 0.245 | 0.123 | Monophenol monooxygenase inhibitor | 0.119 0.062 DBMET00731 0.123 0.06 DBMET02509 | DBMET02509 | |
| 0.027 | 0.254 | 0.163 | M18 aspartyl aminopeptidase inhibitor | 0.163 0.046 DBMET02506 | DBMET02506 | |
| 0.068 | 0.298 | 0.332 | Hepatoprotectant | 0.332 0.022 DBMET00731 0.144 0.116 DBMET02506 0.138 0.123 DBMET02507 0.14 0.121 DBMET00750 0.322 0.024 DBMET02509 | DBMET00731 | |
| 0.122 | 0.353 | 0.245 | Histamine release inhibitor | 0.245 0.159 DBMET00731 | DBMET00731 | |
| 0.049 | 0.292 | 0.123 | Estrogen antagonist | 0.123 0.05 DBMET02505 | DBMET02505 | |
| 0.038 | 0.281 | 0.126 | AMP-activated protein kinase stimulant | 0.126 0.044 DBMET00731 0.104 0.065 DBMET02509 | DBMET00731 | |
| 0.054 | 0.303 | 0.417 | Dual specificity phosphatase inhibitor | 0.138 0.109 DBMET02506 0.417 0.013 DBMET00750 | DBMET00750 | |
| 0.111 | 0.373 | 0.579 | Antibacterial | 0.579 0.023 DBMET00731 0.308 0.13 DBMET00750 0.573 0.024 DBMET02509 | DBMET00731 | |
| 0.055 | 0.343 | 0.146 | Hexokinase inhibitor | 0.146 0.083 DBMET00731 | DBMET00731 | |
| 0.031 | 0.331 | 0.096 | Chelator | 0.096 0.083 DBMET02506 | DBMET02506 | |
| 0.011 | 0.312 | 0.081 | HIV-1 integrase (3'-Processing) inhibitor | 0.064 0.043 DBMET02506 0.081 0.033 DBMET00750 | DBMET00750 | |
| 0.052 | 0.358 | 0.154 | DNA methyltransferase I inhibitor | 0.154 0.1 DBMET02509 | DBMET02509 | |
| 0.064 | 0.38 | 0.133 | Interferon gamma antagonist | 0.133 0.104 DBMET00731 0.127 0.117 DBMET02509 | DBMET00731 | |
| 0.055 | 0.382 | 0.18 | Hemostatic | 0.18 0.042 DBMET00731 0.158 0.059 DBMET02509 | DBMET00731 | |
| 0.007 | 0.337 | 0.113 | Antineoplastic antibiotic | 0.113 0.041 DBMET00731 0.11 0.042 DBMET02509 | DBMET00731 | |
| 0.041 | 0.371 | 0.144 | Cyclooxygenase 3 inhibitor | 0.138 0.059 DBMET00731 0.144 0.054 DBMET02509 | DBMET02509 | |
| 0.047 | 0.392 | 0.398 | Free radical scavenger | 0.151 0.144 DBMET02503 0.151 0.144 DBMET02504 0.154 0.141 DBMET02505 0.398 0.029 DBMET00731 0.236 0.075 DBMET02506 0.195 0.102 DBMET02507 0.396 0.029 DBMET02509 | DBMET00731 | |
| 0.037 | 0.383 | 0.241 | Dual specificity phosphatase 3 inhibitor | 0.241 0.043 DBMET00750 | DBMET00750 | |
| 0.017 | 0.37 | 0.059 | Heparanase inhibitor | 0.059 0.025 DBMET00731 0.055 0.032 DBMET02509 | DBMET00731 | |
| 0.03 | 0.386 | 0.083 | Thioredoxin inhibitor | 0.082 0.078 DBMET00731 0.083 0.075 DBMET02509 | DBMET02509 | |
| 0.05 | 0.406 | 0.146 | Interleukin 6 antagonist | 0.146 0.095 DBMET00731 0.133 0.118 DBMET02509 | DBMET00731 | |
| 0.048 | 0.405 | 0.159 | DNA methylase inhibitor | 0.159 0.109 DBMET02509 | DBMET02509 | |
| 0.013 | 0.37 | 0.06 | Neuraminidase (influenza) inhibitor | 0.06 0.055 DBMET00731 | DBMET00731 | |
| 0.055 | 0.422 | 0.387 | Alpha-glucosidase inhibitor | 0.243 0.192 DBMET00731 0.387 0.121 DBMET02509 | DBMET02509 | |
| 0.102 | 0.469 | 0.351 | Interleukin 2 agonist | 0.351 0.045 DBMET00731 0.324 0.058 DBMET02509 | DBMET00731 | |
| 0.037 | 0.409 | 0.332 | Immunostimulant | 0.332 0.07 DBMET00731 0.265 0.09 DBMET02509 | DBMET00731 | |
| 0.008 | 0.38 | 0.077 | HIV-1 integrase (Strand Transfer) inhibitor | 0.077 0.032 DBMET00750 | DBMET00750 | |
| 0.012 | 0.391 | 0.077 | Protein 50S ribosomal subunit inhibitor | 0.077 0.021 DBMET00731 0.072 0.023 DBMET02509 | DBMET00731 | |
| 0.032 | 0.412 | 0.196 | Anticoagulant | 0.155 0.076 DBMET00731 0.196 0.055 DBMET00750 0.126 0.105 DBMET02509 | DBMET00750 | |
| 0.018 | 0.4 | 0.128 | Topoisomerase I inhibitor | 0.127 0.051 DBMET00731 0.128 0.051 DBMET02509 | DBMET02509 | |
| 0.023 | 0.42 | 0.192 | Protein-tyrosine phosphatase inhibitor | 0.192 0.05 DBMET00750 | DBMET00750 | |
| 0.043 | 0.452 | 0.422 | Antioxidant | 0.422 0.031 DBMET00731 0.211 0.107 DBMET02506 0.176 0.136 DBMET02507 0.2 0.114 DBMET00750 0.41 0.033 DBMET02509 | DBMET00731 | |
| 0.029 | 0.451 | 0.476 | Angiogenesis stimulant | 0.476 0.013 DBMET00731 0.338 0.036 DBMET00750 0.449 0.015 DBMET02509 | DBMET00731 | |
| 0.038 | 0.471 | 0.281 | Nitric oxide antagonist | 0.25 0.051 DBMET00731 0.281 0.044 DBMET02509 | DBMET02509 | |
| 0.035 | 0.475 | 0.098 | Transcription factor NF kappa B stimulant | 0.098 0.041 DBMET00731 0.094 0.045 DBMET02509 | DBMET00731 | |
| 0.05 | 0.494 | 0.395 | Immunosuppressant | 0.368 0.077 DBMET00731 0.395 0.065 DBMET02509 | DBMET02509 | |
| 0.064 | 0.52 | 0.182 | RNA-directed DNA polymerase inhibitor | 0.182 0.128 DBMET00750 | DBMET00750 | |
| 0.013 | 0.47 | 0.069 | HIV-1 integrase inhibitor | 0.069 0.05 DBMET02506 | DBMET02506 | |
| 0.035 | 0.494 | 0.289 | Platelet adhesion inhibitor | 0.289 0.037 DBMET00731 0.286 0.038 DBMET00750 0.274 0.042 DBMET02509 | DBMET00731 | |
| 0.02 | 0.484 | 0.17 | Lipid peroxidase inhibitor | 0.169 0.056 DBMET00731 0.17 0.056 DBMET02509 | DBMET02509 | |
| 0.011 | 0.489 | 0.402 | Cholecystokinin B agonist | 0.402 0.003 DBMET00750 | DBMET00750 | |
| 0.042 | 0.545 | 0.164 | NOS3 expression enhancer | 0.164 0.06 DBMET00731 0.147 0.075 DBMET02509 | DBMET00731 | |
| 0.024 | 0.549 | 0.138 | Cell adhesion inhibitor | 0.138 0.054 DBMET00731 0.133 0.057 DBMET02509 | DBMET00731 | |
| 0.063 | 0.59 | 0.313 | Apoptosis antagonist | 0.313 0.077 DBMET00731 0.304 0.083 DBMET02509 | DBMET00731 | |
| 0.026 | 0.571 | 0.187 | DNA synthesis inhibitor | 0.187 0.143 DBMET00731 | DBMET00731 | |
| 0.003 | 0.573 | 0.203 | Cholecystokinin A agonist | 0.203 0.003 DBMET00750 | DBMET00750 | |
| 0.027 | 0.597 | 0.38 | Tumour necrosis factor alpha release inhibitor | 0.224 0.09 DBMET00731 0.38 0.03 DBMET02509 | DBMET02509 | |
| 0.062 | 0.638 | 0.59 | Antiinflammatory | 0.59 0.056 DBMET00731 0.562 0.064 DBMET02509 | DBMET00731 | |
| 0.003 | 0.582 | 0.242 | Cholecystokinin agonist | 0.242 0.003 DBMET00750 | DBMET00750 | |
| 0.01 | 0.596 | 0.026 | Toll-Like receptor 4 agonist | 0.026 0.02 DBMET00750 0.026 0.02 DBMET02509 | DBMET02509 | |
| 0.003 | 0.616 | 0.091 | Cholecystokinin A antagonist | 0.091 0.01 DBMET00750 | DBMET00750 | |
| 0.005 | 0.637 | 0.052 | NMDA 2B receptor antagonist | 0.052 0.039 DBMET00750 | DBMET00750 | |
| 0.014 | 0.648 | 0.159 | Platelet antagonist | 0.159 0.135 DBMET00731 | DBMET00731 | |
| 0.003 | 0.666 | 0.037 | Cholecystokinin B antagonist | 0.037 0.016 DBMET00750 | DBMET00750 | |
| 0.003 | 0.675 | 0.057 | Cholecystokinin antagonist | 0.057 0.021 DBMET00750 | DBMET00750 | |
| 0.066 | 0.74 | 0.125 | CC chemokine 6 receptor antagonist | 0.125 0.092 DBMET00731 0.123 0.102 DBMET02509 | DBMET00731 | |
| 0.012 | 0.691 | 0.173 | Thrombolytic | 0.173 0.066 DBMET00731 0.157 0.076 DBMET02509 | DBMET00731 | |
| 0.011 | 0.717 | 0.138 | Multidrug resistance-associated protein 1 inhibitor | 0.138 0.032 DBMET00750 | DBMET00750 | |
| 0.018 | 0.735 | 0.217 | Angiogenesis inhibitor | 0.217 0.151 DBMET00750 | DBMET00750 | |
| 0.016 | 0.781 | 0.106 | Toll-Like receptor 4 antagonist | 0.101 0.068 DBMET00731 0.106 0.061 DBMET02509 | DBMET02509 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |